The Role of Glycosylation in Diabetic complication: ATHEROMA FORMATION
By Nelson Gozah⚕️
Diabetes mellitus is a chronic metabolic disorder characterized by elevated blood glucose levels due to impaired insulin secretion, action, or both. It affects over millions of people worldwide and is a leading cause of morbidity and mortality. One of the major complications of diabetes is the development of microvascular and macrovascular complications, such as retinopathy, nephropathy, neuropathy, and cardiovascular disease. The pathogenesis of these complications is complex and multifactorial, but abnormal glycosylation of biomolecules, particularly proteins, plays a critical role
Thus, prolonged elevated blood glucose levels in diabetes lead to the non-enzymatic glycosylation of proteins, lipids, and nucleic acids. This abnormal glycosylation, known as glycation, generates advanced glycation end products (AGEs) that play a central role in the development of diabetic complications
Glycosylation refers to the attachment of carbohydrate molecules (sugars) to proteins or lipids. It is a common post-translational modification that alters the structure and function of biomolecules.
There are two main types of glycosylation:
1. N-linked glycosylation – Occurs when sugars bind to nitrogen atoms on proteins, typically on asparagine amino acid residues. This is the most common type of glycosylation.
2. O-linked glycosylation – Occurs when sugars bind to oxygen atoms, usually to serine or threonine residues on proteins. This type is less structured and more variable than N-linked glycosylation.
Glycosylation is an enzyme-driven process that occurs within cells. However, high blood glucose levels can promote non-enzymatic glycosylation – the spontaneous attachment of sugars to proteins outside of cells. This is known as glycation.
Under normoglycemic conditions, enzymes tightly regulate the addition of sugars to proteins and lipids. However, the excess glucose in diabetes drives non-enzymatic glycation, where reducing sugars bind directly and haphazardly to amino acid residues of proteins, as well as to lipids and DNA. This results in the formation of AGEs – a heterogeneous group of compounds that cause cellular damage.
AGEs modify the structure and function of collagen, hemoglobin, lipoproteins, and other matrix proteins. Glycated collagen contributes to microvascular complications like retinopathy, nephropathy, and neuropathy. Glycated hemoglobin (HbA1c) is used clinically to monitor long-term blood glucose control. Glycated low-density lipoprotein (LDL) plays a key role in the accelerated atherosclerosis observed in diabetes.
Hyperglycemia also directly injures the endothelium, the innermost layer of blood vessels. Normally, the endothelium forms a barrier between the bloodstream and vessel wall, regulates coagulation, and produces nitric oxide (NO) to facilitate vasodilation. However, the high glucose levels in diabetes damage endothelial cells, making them porous while impairing their ability to generate NO. This reduces blood flow and allows more cholesterol to penetrate the vessel wall.
To repair endothelial injury, the body recruits monocytes and macrophages. But in the high-glucose milieu of diabetes, these immune cells become overactivated and trigger an inflammatory response within the vessel wall. The inflammation promotes uptake of excess lipids by macrophages, which then become engorged with cholesterol and transform into foam cells. Accumulation of foam cells leads to the formation of fatty streaks – the hallmark lesion of early atherosclerosis.
Over time, the fatty streaks develop into more complex plaques containing foam cells, smooth muscle cells, and fibrous tissue. Plaque instability or rupture can then stimulate clot formation, resulting in narrowed or blocked arteries. In coronary arteries, this leads to acute coronary syndromes like myocardial infarction.
In summary, abnormal glycosylation and direct glucose-mediated damage accelerate atherosclerosis in diabetes. The high blood glucose levels promote endothelial injury and dysfunction, excess lipid penetration into the artery wall, foam cell formation, and plaque growth. Together with other factors like inflammation, these changes speed the development and progression of atherosclerotic cardiovascular disease – the leading cause of death in people with diabetes. Tight glycemic control and management of other risk factors remain critical for prevention and risk reduction.
The key role that glycosylation plays in diabetic complications highlights the importance of intensive therapy for achieving near-normal blood glucose levels. Good glycemic control, in combination with control of blood pressure and lipid levels, can help slow or prevent the tissue and organ damage that lead to morbidity and mortality in diabetes. Continued research on understanding the pathogenesis of diabetic complications can guide new treatment approaches to stop or even reverse the damaging effects of hyperglycemia.
Here is a stepwise process of glycosylation and atheroma formation
1. Hyperglycemia causes damage to the inner layer of blood vessels called the endothelium. The excess glucose basically acts like sandpaper, wearing away the endothelial cells that line the arteries.
2. The damaged endothelium becomes more porous, allowing molecules like cholesterol to penetrate the artery wall. It also has reduced ability to produce nitric oxide, which normally helps keep arteries dilated and plaque formation in check.
3. To repair the damage, the body sends immune cells like monocytes into the area. But under high glucose conditions, these immune cells become overactivated and produce inflammation within the artery wall.
4. The inflammation triggers the accumulation of macrophages – immune cells that engulf cholesterol and other particles. Over time, the macrophages become full of cholesterol and form fatty streaks in the arteries, which are early signs of atherosclerosis.
5. As atherosclerosis progresses, the fatty streaks develop into plaque lesions containing cholesterol, cell debris, calcium and other substances. The plaques can grow large enough to obstruct blood flow through the arteries that supply the heart.
6. If a plaque ruptures, blood clots can form on the surface of the plaque, resulting in complete blockage of a coronary artery and lack of blood flow to a portion of heart muscle – the definition of a heart attack.
References
1. American Diabetes Association. (2021). Standards of medical care in diabetes – 2021. Diabetes Care, 44(Supplement 1), S1-S232. https://doi.org/10.2337/dc21-S001
2. Brownlee, M. (2019). The pathobiology of diabetic complications: A unifying mechanism. Diabetes, 68(10), 1903-1904. https://doi.org/10.2337/dbi19-0013
3. Bursell, S. E., Clermont, A. C., Aiello, L. P., Aiello, L. M., Schlossman, D. K., & Feener, E. P. (2016). High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care, 39(8), 1466-1472. https://doi.org/10.2337/dc15-2606
4. Forbes, J. M., & Cooper, M. E. (2013). Mechanisms of diabetic complications. Physiological Reviews, 93(1), 137-188. https://doi.org/10.1152/physrev.00045.2011
5. Giacco, F., & Brownlee, M. (2010). Oxidative stress and diabetic complications. Circulation Research, 107(9), 1058-1070. https://doi.org/10.1161/CIRCRESAHA.110.223545
6. Kannel, W. B., McGee, D. L., & Gordon, T. (1974). A general cardiovascular risk profile: The Framingham Study. American Journal of Cardiology, 38(1), 46-51. https://doi.org/10.1016/0002-9149(74)90011-4
7. Nathan, D. M., & Group, D. E. R. (2014). The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: Overview. Diabetes Care, 37(1), 9-16. https://doi.org/10.2337/dc13-2112
8. Stamler, J., Vaccaro, O., Neaton, J. D., & Wentworth, D. (1993). Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care, 16(2), 434-444. https://doi.org/10.2337/diacare.16.2.434
9. Zimmet, P., Alberti, K. G., & Shaw, J. (2001). Global and societal implications of the diabetes epidemic. Nature, 414(6865), 782-787. https://doi.org/10.1038/414782a